Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
2023年6月26日 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most …
The Race for the Next Ozempic - WIRED
2024年7月24日 · Researchers are now racing to develop new anti-obesity medications that are more effective, more convenient, or produce fewer side effects than the ones currently on the …
Lilly launches lower-price weight loss drug without injector pen - CNN
2024年8月27日 · Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will …
FDA Approves New Medication for Chronic Weight Management
Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity (body mass index of 30 kilograms per square...
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to ...
2023年11月8日 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose …
What to know about Zepbound, Eli Lilly’s new weight loss drug - NBC News
2023年11月9日 · A new weight loss drug has been approved that promises to be the most effective medication yet. Zepbound belongs to a new class of medications, alongside Ozempic …
Questions and answers about the new anti-obesity medications
2024年1月1日 · The medications — semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) — are backed by science and stunning accounts of people losing as much as …
F.D.A. Approves New Obesity Drug That Will Compete With Wegovy
2023年11月8日 · Patients who used tirzepatide lost an average of 18 percent of their body weight, according to the F.D.A., when it was taken at its highest dose in a drug trial. That’s compared …
FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPR
2023年11月8日 · New medications to treat obesity and related conditions have become wildly popular, but are expensive, especially when paid for out of pocket. Zepbound will carry a list …
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
2023年11月8日 · Zepbound is the second drug in a new class of obesity medications to be approved for weight loss, following Wegovy. And it is now likely the most effective treatment to …